Greece is witnessing a concerning rise in mpox (monkeypox) cases, as the National Public Health Organization (ΕΟΔΥ) confirms 18 cases reported between November and December 2024. This spike echoes international trends, emphasizing the urgent need for continued vigilance and preventive measures.
Mpox is caused by the mpox virus, which is genetically similar to the smallpox virus but is less transmissible, leading to milder symptoms. According to ΕΟΔΥ, the symptoms include fever, headache, myalgia, lymphadenopathy, chills, exhaustion, and a characteristic rash typically appears 1 to 5 days after symptom onset. The organization cautioned: "While there is no specific treatment, most patients recover completely within weeks."
The mpox virus spreads mainly through close contact with skin lesions or bodily fluids from infected individuals, contact with contaminated objects such as bedding and clothing, and respiratory droplets after prolonged close contact. Recent epidemiological data indicates sexual transmission is the primary avenue for mpox's spread within Greece.
Due to the increase in cases, ΕΟΔΥ has issued several recommendations aimed at high-risk groups, including men who have sex with men (MSM), health professionals, and anyone who has had close contact with someone diagnosed with the virus. The organization advises people to avoid close contact with symptomatic individuals and to seek medical help immediately if they notice unusual skin lesions or symptoms.
For prevention, vaccination against mpox is currently being offered at several centers across the country for individuals considered at greater risk. The vaccination centers include legitimate facilities such as the University General Hospital of Alexandroupolis and the General Hospital of Thessaloniki “AHEPA,” among others. Vaccination days and times vary by location, and interested individuals can call these centers for more details.
ΕΟΔΥ stresses the importance of getting vaccinated as soon as possible for those exposed to confirmed cases—ideally within four days of exposure. This timeline can extend up to fourteen days post-exposure for partial immunity to kick in. The organization remains engaged with local healthcare facilities and international public health entities like the European Center for Disease Prevention and Control (ECDC) and the World Health Organization (WHO) to monitor and address the situation.
Citizens are urged to remain alert for signs of infection and to follow healthcare guidelines if they experience any symptoms which may indicate mpox. Comprehensive information about vaccination strategies and preventive measures is posted on ΕΟΔΥ's official website.
Though the country now faces heightened concerns around monkeypox, experts believe with effective communication, timely vaccination, and adherence to health protocols, the increase can be staved off, ensuring the safety of the community as this unusual disease continues to proliferate.
